General - Press Releases

Date	Title	Company
03-Jan-2024	Mundipharma announces European approval of REZZAYO® (rezafungin) for the treatment of Invasive Candidiasis in adults	Mundipharma
22-Dec-2023	ChemPartner Unveils Highly Anticipated Biology Database	Newswire
20-Dec-2023	Hatch BioFund Announces New Partnership with Brandywine Realty Trust	Businesswire
20-Dec-2023	Global and Regional Cultured Meat Ingredients Market Analysis and Forecast Report 2023-2028 - ResearchAndMarkets.com	Businesswire
20-Dec-2023	Central Nervous System (CNS) Biomarkers Technologies and Global Markets Report - Growing Incidence and Financial Burden of Neurological Disorders - ResearchAndMarkets.com	Businesswire
20-Dec-2023	knownwell Raises $20M Series A From A16Z to Scale the First Patient-Centered Healthcare Home For Those With Overweight and Obesity	Businesswire
20-Dec-2023	Multiply Labs and Akron Bio Partner to Automate the Use of cGMP-Compliant Liquid Cytokines in Cell Therapy Manufacturing	Businesswire
20-Dec-2023	insitro to Present at the 42nd Annual J.P. Morgan Healthcare Conference	Businesswire
20-Dec-2023	Meilleur Technologies Inc. Announces Execution of Manufacturing Agreement with PharmaLogic for Production of the Next-Generation Amyloid PET Imaging Biomarker, NAV4694	Businesswire
20-Dec-2023	Harm Reduction Therapeutics Introduces RiVive™, Over-the-Counter Opioid Overdose Reversal Medication	Businesswire
20-Dec-2023	Simulations Plus Announces First Quarter Fiscal Year 2024 Earnings and Conference Call Date	Businesswire
20-Dec-2023	Mr. Wilbur L. Ross, Former United States Secretary of Commerce, Joins Board of Coya Therapeutics, Inc.	Businesswire
20-Dec-2023	Savara Added to the NASDAQ Biotechnology Index	Businesswire
20-Dec-2023	Enveric Biosciences to Participate in Biotech Showcase 2024 During “J.P. Morgan Week 2024”	Businesswire
20-Dec-2023	Evolus Enters into Licensing Agreement with Symatese to Exclusively Distribute Next-Generation Dermal Fillers in Europe	Businesswire
20-Dec-2023	ZCG-Backed Unimed Appoints Søren Andersen as CEO	Businesswire
20-Dec-2023	858 Therapeutics Expands Leadership Team to Support Transition to the Clinic	Businesswire
20-Dec-2023	Rallybio Announces Preliminary Phase 1 Multiple Ascending Dose Data for RLYB116, an Innovative Subcutaneously Injected Inhibitor of Complement Component 5	Businesswire
20-Dec-2023	Global Melanoma Treatment Market Poised to Surpass $12 Billion by 2028, Driven by Advances in Immunotherapy and Targeted Therapies - ResearchAndMarkets.com	Businesswire
20-Dec-2023	IAMA Therapeutics Announces Approval of Clinical Trial Application (CTA) by the Italian Medicines Agency (AIFA) to Initiate a Phase 1 Study of IAMA-6 for the Treatment of Autism and Epilepsy	Businesswire